Clinical Trials Directory

Trials / Completed

CompletedNCT02128919

Transcranial Direct Current Stimulation (tDCS) As A Treatment For Cigarette Craving and Cognitive Deficits in Schizophrenic

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
Nathan Kline Institute for Psychiatric Research · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This is a study of the effects of tDCS on smoking, craving for cigarettes, cognition, and psychiatric symptoms in schizophrenic patients who are current smokers or have a history of regular cigarette smoking. It assesses smoking with CO monitoring, nicotine and nicotine levels, and craving with QSU scale and response to craving slides. Cognition is measured by MCCB, symptoms are measured by PANSS and hallucination scale. This is a double-blind sham-controlled study with active tDCS 2ma or 20 minutes over 5 days, and sham tDCS for 40 seconds on each sham occasion.

Conditions

Interventions

TypeNameDescription
DEVICEtDCSTranscranial Direct Current Stimulation

Timeline

Start date
2012-04-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2014-05-01
Last updated
2017-08-30
Results posted
2017-08-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02128919. Inclusion in this directory is not an endorsement.

Transcranial Direct Current Stimulation (tDCS) As A Treatment For Cigarette Craving and Cognitive Deficits in Schizophre (NCT02128919) · Clinical Trials Directory